Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person benazeprilat [endoplasmic reticulum lumen]

Class:Id	ChemicalDrug:9619040
_displayName	benazeprilat [endoplasmic reticulum lumen]
_timestamp	2018-12-12 00:29:45
compartment	[Compartment:17957] endoplasmic reticulum lumen
created	[InstanceEdit:9619045] Jassal, Bijay, 2018-09-14
crossReference	[DatabaseIdentifier:9628034] ChEBI:88200
disease	[Disease:9608426] hypertension [Disease:9608422] congestive heart failure [Disease:9611005] myocardial infarction
literatureReference	[LiteratureReference:9615109] Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure [LiteratureReference:9615116] The pharmacokinetics of benazepril relative to other ACE inhibitors
modified	[InstanceEdit:9625666] Jassal, Bijay, 2018-10-22 [InstanceEdit:9627975] Wu, G, 2018-11-05 [InstanceEdit:9631716] Wu, G, 2018-12-12
name	benazeprilat
referenceEntity	[ReferenceTherapeutic:9614924] benazeprilat [Guide to Pharmacology:6375]
stableIdentifier	[StableIdentifier:9619064] R-ALL-9619040.2
(hasMember)	[DefinedSet:9619021] hydrolysed ACEIs [endoplasmic reticulum lumen]
[Change default viewing format]

No pathways have been reviewed or authored by benazeprilat [endoplasmic reticulum lumen] (9619040)